EBC - ON DEMAND
European Bifurcation Club 2014 – EBC 2014 – Bordeaux, France
Cases: tips & tricks and complications
Side branch patency after implantation of the novel DESolve bioresorbable vascular scaffold system in the treatment of de novo coronary lesions
Author: Ricardo A. Costa, Cardiovascular Research Center, Sao Paulo, SP, Brazil
OBJECTIVE
Our aim was to investigate the occurrence of SB occlusion after implantation of the novel DESolve bioresorbable scaffold device in single de novo coronary lesions
CONCLUSION
In the prospective, non-randomized, single-arm, multicenter DESolve Nx trial, SB occlusion – as determined by final TIMI flow < 2, after implantation of the novel DESolve bioresorbable vascular scaffold was relatively low (4%) and was not associated with adverse clinical events during index hospitalization.